The review publication from January 2021 entitled: “pH-responsive antibodies for therapeutic applications” describes, among others such issues as:
- antibodies activated by pH changes;
- pH influence on antibodies crossing the blood-brain barrier;
- pH-dependent antibodies with improved characteristics;
- and many other issues.
The authors are Tomasz Klaus, leader of the antibody group and Sameer Deshmukh from the Science and Innovation Department